CTKB Cytek Biosciences Inc.
Medical Device Company
9.96
+0.06 (+1%)
Previous Close
9.9
Open
10
52 Week Low
7.38
52 Week High
28.7
Market Cap
$1,337,758,825
Shares
134,313,135
Float
100,177,675
Enterprise Value
$1,093,380,811
Volume
527,683
Av. Daily Volume
1,138,457
Live cash est
$88,666,444,222
Cash Burn
N/A
No. Mths Cash
12
Insiders %
0.2
Total debt to equity
4.35
Earnings Date
01/01/2001
EPS EST.
1.82
EPS PRIOR.
1.82
EPS
1.82
Rev guidance
$10,459,000,000
Biotech Analyst Ratings
Analyst | Action | Rating Now | PT Prior | PT Now | Last Updated |
---|---|---|---|---|---|
Piper Sandler | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 05/16/2022 |
Morgan Stanley | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 05/13/2022 |
Goldman Sachs | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 05/12/2022 |
Goldman Sachs | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 04/13/2022 |